Medexus Pharmaceuticals (FRA:P731) Beginning Cash Position : €6.7 Mil (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Medexus Pharmaceuticals Beginning Cash Position?

Medexus Pharmaceuticals's Beginning Cash Position for the quarter that ended in Dec. 2024 was €6.7 Mil.

Medexus Pharmaceuticals's quarterly Beginning Cash Position increased from Jun. 2024 (€4.9 Mil) to Sep. 2024 (€7.6 Mil) but then declined from Sep. 2024 (€7.6 Mil) to Dec. 2024 (€6.7 Mil).

Medexus Pharmaceuticals's annual Beginning Cash Position declined from Mar. 2022 (€17.0 Mil) to Mar. 2023 (€9.4 Mil) but then increased from Mar. 2023 (€9.4 Mil) to Mar. 2024 (€12.0 Mil).

Medexus Pharmaceuticals Beginning Cash Position Historical Data

The historical data trend for Medexus Pharmaceuticals's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medexus Pharmaceuticals Beginning Cash Position Chart

Medexus Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Beginning Cash Position

Get a 7-Day Free Trial

19.78

4.40

16.98

9.36

12.02

Medexus Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Beginning Cash Position	Get a 7-Day Free Trial															17.88	7.56	4.88	7.62	6.66

Medexus Pharmaceuticals Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Medexus Pharmaceuticals Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Medexus Pharmaceuticals's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Medexus Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (FRA:P731) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

MEDXF:USA MDP:Canada

Address

10 King Street East, Suite 600, Toronto, ON, CAN, M5C 1C3

Website

https://www.medexus.com

Medexus Pharmaceuticals Inc is a specialty pharmaceutical company with a powerful North American commercial platform and a growing portfolio of inventive and rare disease treatment solutions. The company's focus is on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology.

Medexus Pharmaceuticals Headlines

No Headlines